Sarcoidosis

Xeljanz (Tofacitinib) Might Be Successful In Treating Sarcoidosis – Sarcoidosis News

Posted by Basil René on

Xeljanz is a partial inhibitor of the JAK enzyme that has been used off-label for the treatment of sarcoidosis and is being studied in clinical trials.
— Read on sarcoidosisnews.com/xeljanz-tofacitinib/

Published by Basil René

I am a professional chef that loves writing and photography. I was also diagnosed with pulmonary and cardiac sarcoidosis. This blog is a place to share my experiences and photography.